These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 28392500)

  • 1. Metabolism and proteomics of large and small dense LDL in combined hyperlipidemia: effects of rosuvastatin.
    Thongtang N; Diffenderfer MR; Ooi EMM; Barrett PHR; Turner SM; Le NA; Brown WV; Schaefer EJ
    J Lipid Res; 2017 Jul; 58(7):1315-1324. PubMed ID: 28392500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rosuvastatin Enhances the Catabolism of LDL apoB-100 in Subjects with Combined Hyperlipidemia in a Dose Dependent Manner.
    Le NA; Diffenderfer MR; Thongtang N; Ooi EM; Barrett PH; Horvath KV; Dolnikowski GG; Asztalos BF; Schaefer EJ; Brown WV
    Lipids; 2015 May; 50(5):447-58. PubMed ID: 25809021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of small dense LDL-C/large buoyant LDL-C ratio as an independent risk factor in patients with type 2 diabetes mellitus and metabolic syndrome.
    Wang C; Li Y; Peng P; Lin H; Zhu Y; Xu X; Wu P; Zhang Y; Xu T; Ren J; Xu H; Dong G; Xu Y; Jiang H; Zhao J; Zhai Y; Zai G
    Ann Biol Clin (Paris); 2024 Jun; 82(2):174-186. PubMed ID: 38832689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-density lipoprotein particle size, central obesity, cardiovascular fitness, and insulin resistance syndrome markers in obese youths.
    Kang HS; Gutin B; Barbeau P; Litaker MS; Allison J; Le NA
    Int J Obes Relat Metab Disord; 2002 Aug; 26(8):1030-5. PubMed ID: 12119567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small-dense LDL cholesterol/large-buoyant LDL cholesterol ratio as an excellent marker for indicating lipodystrophy in HIV-infected patients.
    Srisawasdi P; Suwalak T; Sukasem C; Chittamma A; Pocathikorn A; Vanavanan S; Puangpetch A; Santon S; Chantratita W; Kiertiburanakul S; Kroll MH
    Am J Clin Pathol; 2013 Oct; 140(4):506-15. PubMed ID: 24045547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of weight change on apolipoprotein B-containing emerging atherosclerotic cardiovascular disease (ASCVD) risk factors.
    Dansinger ML; Williams PT; Superko HR; Schaefer EJ
    Lipids Health Dis; 2019 Jul; 18(1):154. PubMed ID: 31311555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triglyceride-Rich Lipoprotein Cholesterol, Small Dense LDL Cholesterol, and Incident Cardiovascular Disease.
    Duran EK; Aday AW; Cook NR; Buring JE; Ridker PM; Pradhan AD
    J Am Coll Cardiol; 2020 May; 75(17):2122-2135. PubMed ID: 32354380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of rosuvastatin on electronegative LDL as characterized by capillary isotachophoresis: the ROSARY Study.
    Zhang B; Matsunaga A; Rainwater DL; Miura S; Noda K; Nishikawa H; Uehara Y; Shirai K; Ogawa M; Saku K
    J Lipid Res; 2009 Sep; 50(9):1832-41. PubMed ID: 19056704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid turnover of apolipoprotein C-III-containing triglyceride-rich lipoproteins contributing to the formation of LDL subfractions.
    Zheng C; Khoo C; Ikewaki K; Sacks FM
    J Lipid Res; 2007 May; 48(5):1190-203. PubMed ID: 17314277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-dependent effect of rosuvastatin on apolipoprotein B-100 kinetics in the metabolic syndrome.
    Ooi EM; Barrett PH; Chan DC; Nestel PJ; Watts GF
    Atherosclerosis; 2008 Mar; 197(1):139-46. PubMed ID: 17416370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small, dense LDL cholesterol and apolipoprotein B: relationship with serum lipids and LDL size.
    Vekic J; Zeljkovic A; Jelic-Ivanovic Z; Spasojevic-Kalimanovska V; Bogavac-Stanojevic N; Memon L; Spasic S
    Atherosclerosis; 2009 Dec; 207(2):496-501. PubMed ID: 19632678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Small-Dense LDL, HDL2, 3].
    Hirano T
    Rinsho Byori; 2016 Jun; 64(6):636-642. PubMed ID: 30695317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The small dense LDL particle/large buoyant LDL particle ratio is associated with glucose metabolic status in pregnancy.
    Chen Y; Du M; Xu J; Chen D
    Lipids Health Dis; 2017 Dec; 16(1):244. PubMed ID: 29241449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preferential reduction of very low density lipoprotein-1 particle number by fenofibrate in type IIB hyperlipidemia: consequences for lipid accumulation in human monocyte-derived macrophages.
    Milosavljevic D; Griglio S; Le Naour G; Chapman MJ
    Atherosclerosis; 2001 Mar; 155(1):251-60. PubMed ID: 11223449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive assessment of lipoprotein subfraction profiles according to glucose metabolism status, and association with insulin resistance in subjects with early-stage impaired glucose metabolism.
    Lee JE; Min SH; Lee DH; Oh TJ; Kim KM; Moon JH; Choi SH; Park KS; Jang HC; Lim S
    Int J Cardiol; 2016 Dec; 225():327-331. PubMed ID: 27756036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human apolipoprotein (Apo) B-48 and ApoB-100 kinetics with stable isotopes.
    Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 1999 Dec; 19(12):2966-74. PubMed ID: 10591677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors ("statins") in familial combined hyperlipidemia.
    Schonfeld G; Aguilar-Salina C; Elias N
    Am J Cardiol; 1998 Feb; 81(4A):43B-46B. PubMed ID: 9526813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of low-dose rosuvastatin on plasma levels of cholesterol and oxidized low-density lipoprotein in 3 ultracentrifugally separated low-density lipoprotein subfractions.
    Homma K; Homma Y; Ozawa H; Shiina Y; Shibata T; Yoshida T; Hasegawa K; Kanda T; Tokuyama H; Wakino S; Hayashi K; Itoh H; Hori S
    J Clin Lipidol; 2015; 9(6):751-757. PubMed ID: 26687695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 12-week, prospective, open-label analysis of the effect of rosuvastatin on triglyceride-rich lipoprotein metabolism in patients with primary dyslipidemia.
    Kostapanos MS; Milionis HJ; Filippatos TD; Nakou ES; Bairaktari ET; Tselepis AD; Elisaf MS
    Clin Ther; 2007 Jul; 29(7):1403-14. PubMed ID: 17825691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intercorrelations of lipoprotein subfractions and their covariation with lifestyle factors in healthy men.
    Parlesak A; Eckoldt J; Winkler K; Bode CJ; Schäfer C
    J Clin Biochem Nutr; 2014 May; 54(3):174-80. PubMed ID: 24895480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.